25:
393:, Italy. It employed over 4,750 people with worldwide revenues of USD 2,586.4 million (2005). It had eight biotechnology products on the market, and more than 25 ongoing preclinical and clinical development projects at the end of 2005. Serono Headquarters and the Geneva research site moved to a brand new campus (Horizon Secheron) in the heart of Geneva in 2006. This facility and the headquarters were closed by Merck KGaA in 2013. The building was sold back to Berterelli family.
874:
862:
380:
Serono operated in 44 countries, with manufacturing facilities in eight countries and sales in over 90 countries. Main manufacturing sites were in
Switzerland, Italy, Spain and France; a fifth facility in Israel was closed in 2004 owing to its obsolescence. Research and development facilities were
367:. The process of merging started in January 2007 after various business regulatory reviews and phases were complete. Until that time, Serono and Merck KGaA operated as separate entities. The new, combined entity,
371:
is the size of other large biotechs. In 2011, a decision was made to close the Geneva headquarters and move the headquarters to
Darmstadt, Germany resulting in job losses to most of the employees in Geneva.
561:
63:
924:
929:
914:
919:
904:
949:
899:
944:
266:
by Dr. Piero Donini. Serono was incorporated in 1987 and the holding company, Ares-Serono S.A., changed its name to Serono S.A. in May 2000.
939:
492:
418:
909:
934:
588:
535:
359:. Its headquarters was in Geneva, within the new Serono facilities. The US operations remain near Boston and was renamed here
331:. Through the acquisition in 1997 of GBRI from GlaxoWelcome, becoming its Geneva based research institute named SPRI, and the
735:
402:
530:
511:
429:
Serono provides
Fertility LifeLines as a free and confidential source of information to infertility patients.
405:
to resolve civil and criminal allegations that the company engaged in a fraudulent scheme to promote the drug
355:
paid CHF 1,100 for each share. The new entity, which merges Serono with Merck's
Ethicals division, is called
641:
468:
336:
332:
852:
581:
839:
728:
636:
556:
758:
87:
489:
813:
574:
386:
894:
721:
8:
656:
382:
328:
301:
274:
157:
38:
Please help update this article to reflect recent events or newly available information.
878:
646:
297:
278:
179:
73:
262:. A key step in its development was the discovery of a method of extracting urinary
490:#05-545: 10-17-05 SERONO TO PAY $ 704 MILLION FOR THE ILLEGAL MARKETING OF AIDS DRUG
866:
792:
414:
818:
763:
515:
496:
452:
442:
681:
364:
292:
The eight biotechnology products are available in four core therapeutic areas:
270:
215:
888:
780:
651:
410:
235:
232:
83:
413:
and paid out illegal kickbacks for prescribing the drug in violation of the
823:
808:
768:
666:
597:
368:
356:
263:
744:
697:
309:
305:
286:
247:
243:
312:, where Serono has launched biologics in Europe for moderate-to-severe
631:
626:
616:
352:
348:
335:
spin-off, Serono also nursed the emergence of now a commercial leading
317:
282:
220:
139:
785:
661:
621:
313:
293:
508:
676:
611:
406:
324:
320:
for treatments for HIV-associated wasting and growth deficiencies.
173:
671:
566:
239:
713:
401:
In 2005, Serono agreed to a $ 704 million settlement with the
62:
390:
259:
255:
184:
549:
246:. It was acquired by the German pharmaceutical company
850:
886:
925:Pharmaceutical companies disestablished in 2006
930:Biotechnology companies disestablished in 2006
729:
582:
915:Pharmaceutical companies established in 1906
736:
722:
589:
575:
562:Serono Pharmaceutical Company Intelligence
61:
296:for the treatment of relapsing forms of
250:in 2006. The company was founded as the
920:Manufacturing companies based in Geneva
905:Pharmaceutical companies of Switzerland
448:
432:
419:ninth largest pharmaceutical settlement
16:Switzerland based biotechnology company
950:Swiss companies disestablished in 2006
900:Biotechnology companies of Switzerland
887:
536:Pharmaceutical industry in Switzerland
424:
323:The company also conducts research in
945:Italian companies established in 1906
717:
570:
342:
18:
940:Swiss companies established in 1906
438:
13:
509:My Fertility | Fertility Lifelines
417:. The settlement is, to date, the
14:
961:
541:
471:. Evaluate Group. 23 January 2001
351:in Sept. 2006 for €10.6 billion;
910:Defunct companies of Switzerland
872:
860:
596:
531:List of pharmaceutical companies
252:Serono Pharmacological Institute
23:
743:
501:
483:
461:
1:
935:2006 mergers and acquisitions
557:Merck KGaA corporate homepage
375:
363:due to trademark issues with
642:Human chorionic gonadotropin
469:"Serono 2000 Sales Up 15.2%"
269:Serono develops and markets
254:by Cesare Serono in 1906 in
7:
524:
337:massive parallel sequencing
333:Manteia Predictive Medicine
122:; 18 years ago
10:
966:
396:
347:36% of Serono was sold to
840:Emanuel Merck Lectureship
832:
801:
751:
690:
637:Gonadotropin preparations
604:
495:November 2, 2013, at the
455:. Retrieved July 3, 2005.
445:. Retrieved July 3, 2005.
214:
192:
164:
153:
145:
134:
116:
108:
93:
79:
69:
60:
32:This article needs to be
759:AZ Electronic Materials
814:Friedrich Jacob Merck
403:Department of Justice
160:(former Headquarters)
514:May 4, 2014, at the
433:Notes and references
657:Luteinizing hormone
425:Fertility LifeLines
383:Geneva, Switzerland
365:Merck & Co./MSD
329:autoimmune diseases
302:reproductive health
275:reproductive health
170:Claudio Bertarelli
158:Geneva, Switzerland
57:
647:Interferon beta-1a
343:Sale to Merck KGaA
304:for treatments of
298:multiple sclerosis
279:multiple sclerosis
180:Ernesto Bertarelli
55:
848:
847:
711:
710:
421:in U.S. history.
316:, and growth and
273:in the fields of
238:headquartered in
226:
225:
202:Ovidrel/Ovitrelle
188:
177:
53:
52:
957:
877:
876:
875:
865:
864:
863:
856:
793:Versum Materials
738:
731:
724:
715:
714:
591:
584:
577:
568:
567:
553:
552:
550:Official website
518:
505:
499:
487:
481:
480:
478:
476:
465:
451:
441:
415:False Claims Act
182:
171:
130:
128:
123:
104:
102:
65:
58:
54:
48:
45:
39:
27:
26:
19:
965:
964:
960:
959:
958:
956:
955:
954:
885:
884:
883:
873:
871:
861:
859:
851:
849:
844:
828:
819:George W. Merck
797:
764:Merck Millipore
747:
742:
712:
707:
686:
600:
595:
548:
547:
544:
527:
522:
521:
516:Wayback Machine
506:
502:
497:Wayback Machine
488:
484:
474:
472:
467:
466:
462:
435:
427:
399:
378:
345:
281:, growth &
271:pharmaceuticals
209:
207:
205:
203:
201:
199:
197:
178:
167:
126:
124:
121:
100:
98:
86:
49:
43:
40:
37:
28:
24:
17:
12:
11:
5:
963:
953:
952:
947:
942:
937:
932:
927:
922:
917:
912:
907:
902:
897:
882:
881:
869:
846:
845:
843:
842:
836:
834:
830:
829:
827:
826:
821:
816:
811:
805:
803:
799:
798:
796:
795:
790:
789:
788:
778:
777:
776:
766:
761:
755:
753:
749:
748:
741:
740:
733:
726:
718:
709:
708:
706:
705:
700:
694:
692:
688:
687:
685:
684:
682:Tegafur/uracil
679:
674:
669:
664:
659:
654:
649:
644:
639:
634:
629:
624:
619:
614:
608:
606:
602:
601:
594:
593:
586:
579:
571:
565:
564:
559:
554:
543:
542:External links
540:
539:
538:
533:
526:
523:
520:
519:
500:
482:
459:
458:
457:
456:
453:2004 Form 20-F
446:
443:2002 Form 20-F
434:
431:
426:
423:
411:off-label uses
398:
395:
381:maintained in
377:
374:
344:
341:
224:
223:
218:
212:
211:
194:
190:
189:
168:
165:
162:
161:
155:
151:
150:
147:
143:
142:
136:
132:
131:
118:
114:
113:
110:
106:
105:
95:
91:
90:
88:Pharmaceutical
81:
77:
76:
71:
67:
66:
51:
50:
31:
29:
22:
15:
9:
6:
4:
3:
2:
962:
951:
948:
946:
943:
941:
938:
936:
933:
931:
928:
926:
923:
921:
918:
916:
913:
911:
908:
906:
903:
901:
898:
896:
893:
892:
890:
880:
870:
868:
858:
857:
854:
841:
838:
837:
835:
831:
825:
822:
820:
817:
815:
812:
810:
807:
806:
804:
800:
794:
791:
787:
784:
783:
782:
781:Sigma-Aldrich
779:
775:
772:
771:
770:
767:
765:
762:
760:
757:
756:
754:
750:
746:
739:
734:
732:
727:
725:
720:
719:
716:
704:
701:
699:
696:
695:
693:
689:
683:
680:
678:
675:
673:
670:
668:
665:
663:
660:
658:
655:
653:
652:Levothyroxine
650:
648:
645:
643:
640:
638:
635:
633:
630:
628:
625:
623:
620:
618:
615:
613:
610:
609:
607:
603:
599:
592:
587:
585:
580:
578:
573:
572:
569:
563:
560:
558:
555:
551:
546:
545:
537:
534:
532:
529:
528:
517:
513:
510:
504:
498:
494:
491:
486:
470:
464:
460:
454:
450:
447:
444:
440:
437:
436:
430:
422:
420:
416:
412:
408:
404:
394:
392:
388:
384:
373:
370:
366:
362:
358:
354:
350:
340:
338:
334:
330:
326:
321:
319:
315:
311:
307:
303:
299:
295:
290:
288:
284:
280:
276:
272:
267:
265:
264:gonadotropins
261:
257:
253:
249:
245:
241:
237:
234:
233:biotechnology
230:
222:
219:
217:
213:
195:
191:
186:
181:
175:
169:
163:
159:
156:
152:
148:
144:
141:
137:
133:
119:
115:
112:Cesare Serono
111:
107:
96:
92:
89:
85:
84:Biotechnology
82:
78:
75:
72:
68:
64:
59:
47:
35:
30:
21:
20:
824:Merck family
809:Alfred Bader
773:
769:Merck Serono
752:Subsidiaries
702:
667:Mitoxantrone
598:Merck Serono
503:
485:
473:. Retrieved
463:
449:
439:
428:
400:
379:
369:Merck Serono
360:
357:Merck Serono
346:
339:technology.
322:
291:
268:
251:
228:
227:
154:Headquarters
149:Merck Serono
138:Acquired by
70:Company type
41:
33:
895:Merck Group
879:Switzerland
745:Merck Group
698:Merck Group
387:Boston, USA
310:dermatology
306:infertility
287:dermatology
244:Switzerland
221:Merck Group
140:Merck Group
56:Serono S.A.
44:August 2017
889:Categories
632:Efalizumab
627:Cladribine
617:Bisoprolol
376:Facilities
361:EMD Serono
353:Merck KGaA
349:Merck KGaA
318:metabolism
283:metabolism
166:Key people
867:Companies
786:Carbolabs
662:Metformin
622:Cetuximab
314:psoriasis
294:neurology
208:Zorbtive
146:Successor
677:Serostim
612:Avelumab
605:Products
525:See also
512:Archived
493:Archived
407:Serostim
325:oncology
204:Serostim
193:Products
174:Chairman
80:Industry
853:Portals
833:Related
691:Related
475:23 June
397:Lawsuit
236:company
210:Raptiva
200:Luveris
198:Gonal-f
125: (
117:Defunct
109:Founder
99: (
94:Founded
34:updated
802:People
774:Serono
703:Serono
672:Saizen
389:, and
240:Geneva
231:was a
229:Serono
216:Parent
206:Saizen
391:Ivrea
260:Italy
248:Merck
196:Rebif
507:<
477:2018
409:for
327:and
285:and
256:Rome
135:Fate
127:2006
120:2006
101:1906
97:1906
185:CEO
74:S.A
891::
385:,
308:,
300:,
289:.
277:,
258:,
242:,
855::
737:e
730:t
723:v
590:e
583:t
576:v
479:.
187:)
183:(
176:)
172:(
129:)
103:)
46:)
42:(
36:.
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
